Rupinder Sodhi, MD
Nephrology · Maywood, ILNPI 1518195049
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Veloxis Pharmaceuticals, Inc. accounts for 75.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $25,852 and has fallen 81.8% since, to $4,702 in 2023. Among nephrology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 92 payments — averaging $936.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$65K
- Mallinckrodt Hospital Products Inc.$9K
- Sanofi-aventis U.S. LLC$7K
- Takeda Pharmaceuticals U.S.A., Inc.$5K
- Eurofins Viracor, LLC$280
- Fujifilm Healthcare Americas Corporation$141
- plus $99 from 2 others
What the payments were for
- Consulting fees$36,98143%
- Speaking & faculty fees$19,47923%
- Travel & lodging$24,07428%
- Food & beverage$5,6557%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 67 | $64,988 |
| Mallinckrodt Hospital Products Inc. | 8 | $8,520 |
| Sanofi-aventis U.S. LLC | 6 | $6,933 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $5,228 |
| Eurofins Viracor, LLC | 1 | $280 |
| Fujifilm Healthcare Americas Corporation | 2 | $141 |
| Johnson & Johnson | 1 | $88 |
| Mallinckrodt Enterprises LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$83,222
- ACTHAR$8,429
- THYMOGLOBULIN$6,933
- LIVTENCITY$5,228
How this compares
$86,189 in reported general payments places this provider in the 95th percentile of 524 nephrology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 23 | $32,952 |
| Cinacalcet Hcl | 39 | $25,567 |
| Envarsus XrTacrolimus | 19 | $18,728 |
| Atovaquone | 16 | $12,756 |
| Valganciclovir Hcl | 25 | $3,808 |
| Tacrolimus | 27 | $3,509 |
| Nifedipine ErNifedipine | 48 | $2,344 |
| Prednisone | 158 | $1,293 |
| Carvedilol | 131 | $1,093 |
| Chlorthalidone | 57 | $748 |
| Tamsulosin Hcl | 41 | $717 |
| Losartan Potassium | 58 | $669 |
| Calcitriol | 29 | $523 |
| Atorvastatin Calcium | 56 | $467 |
| Rosuvastatin Calcium | 13 | $415 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Maywood
- Holly KramerMaywood$89K
- Myles WolfChicago$2.1M
- Mohammed AhmedBolingbrook$1.1M
- Anis RaufHinsdale$453K
- Juan LermaEvergreen Park$351K
- Stuart SpragueEvanston$337K
- Suneel UdaniHinsdale$336K
- Susan QuagginChicago$262K
- Nicole StankusChicago$235K
- Omaima DeganiGurnee$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.